A Mouse Model of Familial Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

A Mouse Model of Familial Hypertrophic Cardiomyopathy

Published:1996-05-03 Issue:5262 Volume:272 Page:731-734
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Geisterfer-Lowrance Anja A. T.¹,Christe Michael¹,Conner David A.¹,Ingwall Joanne S.²,Schoen Frederick J.³,Seidman Christine E.⁴,Seidman J. G.¹

Affiliation:

1. A. A. T. Geisterfer-Lowrance, M. Christe, D. A. Conner, J. G. Seidman, Howard Hughes Medical Institute and Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.

2. J. S. Ingwall, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

3. F. J. Schoen, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

4. C. E. Seidman, Howard Hughes Medical Institute, Brigham and Women's Hospital, 75 Francis Street, Boston MA 02115, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference18 articles.

1. CHRISTE M unpublished data.

2. CILAZAPRIL TREATMENT DEPRESSES VENTRICULAR-FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS;CHRISTE M.E.;AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY,1994

3. GEISTERFERLOWRA AA unpublished data.

4. INTRODUCTION OF A SUBTLE MUTATION INTO THE HOX-2.6 LOCUS IN EMBRYONIC STEM-CELLS;HASTY P;NATURE,1991

5. ALTERED HEPATIC TRANSPORT OF IMMUNOGLOBULIN-A IN MICE LACKING THE J-CHAIN;HENDRICKSON B.A.;JOURNAL OF EXPERIMENTAL MEDICINE,1995

Cited by 485 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy;Circulation;2023-12-05

2. Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling;Journal of Molecular and Cellular Cardiology Plus;2023-12

3. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non–β-Blocking R-Enantiomer Carvedilol;Circulation;2023-11-21

4. Advances in Hypertrophic Cardiomyopathy Disease Modeling using Human iPSC-derived Cardiomyocytes;Canadian Journal of Cardiology;2023-11

5. Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment;Frontiers in Bioengineering and Biotechnology;2023-09-08